These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 9071522)
1. Grafting and the risk of hepatitis transmission: is there reason to be cautious? Are we cautious enough? Sugar J; Mannis M Cornea; 1997 Mar; 16(2):123-4. PubMed ID: 9071522 [No Abstract] [Full Text] [Related]
2. Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Hoft RH; Pflugfelder SC; Forster RK; Ullman S; Polack FM; Schiff ER Cornea; 1997 Mar; 16(2):132-7. PubMed ID: 9071524 [TBL] [Abstract][Full Text] [Related]
3. Should antibody to hepatitis B core antigen be tested in routine screening of donor corneas for transplant? Mattern RM; Cavanagh HD Cornea; 1997 Mar; 16(2):138-45. PubMed ID: 9071525 [TBL] [Abstract][Full Text] [Related]
4. Assessment of the infectivity of corneal buttons taken from hepatitis B surface antigen seropositive donors. O'Day D Surv Ophthalmol; 1995; 40(1):80. PubMed ID: 8545807 [No Abstract] [Full Text] [Related]
5. Testing for hepatitis B surface antigen in processing donor tissue for penetrating keratoplasty. Migden MR; Dennis WH; Clinch TE Am J Ophthalmol; 1996 Sep; 122(3):439-42. PubMed ID: 8794725 [TBL] [Abstract][Full Text] [Related]
6. The prevalence of positive hepatitis B, hepatitis C, and HIV serology in cornea donors prescreened by medical and social history in Ontario, Canada. Armstrong SA; Gangam N; Chipman ML; Rootman DS Cornea; 1997 Sep; 16(5):512-6. PubMed ID: 9294680 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors. Challine D; Chevaliez S; Pawlotsky JM Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749 [TBL] [Abstract][Full Text] [Related]
8. The use of medical and social history as prescreening to eliminate cornea donors at risk of having hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV). Davis AR Cornea; 1998 Jul; 17(4):457-8. PubMed ID: 9676925 [No Abstract] [Full Text] [Related]
10. Donor screening for hepatitis B virus infection in a cell and tissue bank. Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905 [TBL] [Abstract][Full Text] [Related]
11. Review of the risk of HIV infection through corneal transplantation in the United States. Caron MJ; Wilson R J Am Optom Assoc; 1994 Mar; 65(3):173-8. PubMed ID: 8201168 [TBL] [Abstract][Full Text] [Related]
12. Transplantation of corneal tissue from donors with diseases of the central nervous system. Hogan RN; Cavanagh HD Cornea; 1995 Nov; 14(6):547-53. PubMed ID: 8575171 [TBL] [Abstract][Full Text] [Related]
13. Transmission of viruses through corneal transplantation. Robert PY; Adenis JP; Denis F; Ranger-Rogez S Clin Lab; 2005; 51(7-8):419-23. PubMed ID: 16122153 [TBL] [Abstract][Full Text] [Related]
15. Factors affecting the serological testing of cadaveric donor cornea. Raj A; Mittal G; Bahadur H Indian J Ophthalmol; 2018 Jan; 66(1):61-65. PubMed ID: 29283125 [TBL] [Abstract][Full Text] [Related]
16. Detection of hepatitis B virus DNA by in situ tissues hybridization in corneal of HBsAG positive donors. Helmy MF; Ahmed HM; Saber MA J Egypt Public Health Assoc; 1995; 70(3-4):243-55. PubMed ID: 17214156 [TBL] [Abstract][Full Text] [Related]